Literature DB >> 23345394

The Shc family protein adaptor, Rai, acts as a negative regulator of Th17 and Th1 cell development.

Maria Teresa Savino1, Cristina Ulivieri, Giacomo Emmi, Domenico Prisco, Giulia De Falco, Barbara Ortensi, Enrico Beccastrini, Lorenzo Emmi, Giuliana Pelicci, Mario M D'Elios, Cosima T Baldari.   

Abstract

Rai, a Shc adapter family member, acts as a negative regulator of antigen receptor signaling in T and B cells. Rai(-/-) mice develop lupus-like autoimmunity associated to the spontaneous activation of self-reactive lymphocytes. Here, we have addressed the potential role of Rai in the development of the proinflammatory Th1 and Th17 subsets, which are centrally implicated in the pathogenesis of a number of autoimmune diseases, including lupus. We show that Rai(-/-) mice display a spontaneous Th1/Th17 bias. In vitro polarization experiments on naive and effector/memory CD4(+) T cells demonstrate that Rai(-/-) favors the development and expansion of Th17 but not Th1 cells, indicating that Rai modulates TCR signaling to antagonize the pathways driving naive CD4(+) T cell differentiation to the Th17 lineage, while indirectly limiting Th1 cell development in vivo. Th1 and Th17 cell infiltrates were found in the kidneys of Rai(-/-) mice, providing evidence that Rai(-/-) contributes to the development of lupus nephritis, not only by enhancing lymphocyte activation but also by promoting the development and expansion of proinflammatory effector T cells. Interestingly, T cells from SLE patients were found to have a defect in Rai expression, suggesting a role for Rai in disease pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23345394     DOI: 10.1189/jlb.0712331

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  3 in total

1.  The involvement of T regulatory lymphocytes in a cohort of lupus nephritis patients: a pilot study.

Authors:  Antonella Afeltra; Antonietta Gigante; Domenico Paolo Emanuele Margiotta; Chiara Taffon; Rosario Cianci; Biagio Barbano; Marta Liberatori; Antonio Amoroso; Filippo Rossi Fanelli
Journal:  Intern Emerg Med       Date:  2015-02-27       Impact factor: 3.397

Review 2.  Pathogenesis and potential therapeutic targets in systemic lupus erythematosus: from bench to bedside.

Authors:  D Squatrito; G Emmi; E Silvestri; L Ciucciarelli; M M D'Elios; D Prisco; L Emmi
Journal:  Auto Immun Highlights       Date:  2014-08-14

3.  Interleukin-17/Interleukin-21 and Interferon-γ producing T cells specific for β2 Glycoprotein I in atherosclerosis inflammation of systemic lupus erythematosus patients with antiphospholipid syndrome.

Authors:  Marisa Benagiano; Maria Orietta Borghi; Jacopo Romagnoli; Michael Mahler; Chiara Della Bella; Alessia Grassi; Nagaja Capitani; Giacomo Emmi; Arianna Troilo; Elena Silvestri; Lorenzo Emmi; Heba Alnwaisri; Jacopo Bitetti; Simona Tapinassi; Domenico Prisco; Cosima Tatiana Baldari; Pier Luigi Meroni; Mario Milco D'Elios
Journal:  Haematologica       Date:  2019-03-14       Impact factor: 9.941

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.